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1.  General Considerations 
All operations were carried out under a protective dinitrogen atmosphere, either in a glovebox or 
on a vacuum manifold. Benzene-d6, toluene-d8 and other solvents used were dried by vacuum 
transfer either from sodium/benzophenone or from “titanocene”.1 Zirconocene complexes used as 
starting materials were either purchased from Strem Chemicals, Newburyport or prepared in our 
laboratories according to published procedures (see Table 1 of the text). Trimethylaluminum, 
triisobutylaluminum, diisobutylaluminum hydride, diisobutylaluminum chloride and 
trioctylaluminum were used as obtained from Aldrich Chemical Company, Milwaukee. Lithium 
aluminum hydride was obtained from Aldrich Chemical Company and purified prior to use (see 
below). MAO was obtained as a 30% toluene solution from Albermarle and dried at 50 ºC for 3 
hours under vacuum to yield a free flowing white powder.  
 
NMR spectra were obtained using Varian Inova 500 or Mercury 300 spectrometers. Chemical 
shifts are referenced to residual solvents peaks, 7.16 ppm for benzene and 7.00 ppm for the 
central aromatic proton resonance of toluene. UV-vis spectra were recorded on an Agilent 8453 
spectrometer. X-ray diffraction data were collected on a Bruker KAPPA APEXII X-ray 
diffractometer. 
 
2.  Synthesis of HAlMe2 
HAlMe2 was synthesized in analogy to previous literature
2. Commercial LiAlH4 was purified by 
extraction of the gray commercial solid with Et2O in a swivel frit on the high-vacuum line. The 
clear solution was filtered and then the Et2O was removed in vacuo to yield pure LiAlH4 as a 
white powder. In a glove box a 50 mL pear-shaped flask was charged with 1.2 g (32 mmol) of 
purified LiAlH4 and 2.7 mL (28 mmol, 0.9 equiv) of AlMe3. A swivel frit was attached and the 
 3 
apparatus was taken to the high-vacuum line, where 15 mL benzene was vacuum-transferred in 
from a storage flask containing sodium/benzophenone. The mixture was heated to 75 ºC under 
argon with stirring for 2 hours, filtered hot and then cooled in an ice bath. Benzene was removed 
in vacuo to yield HAlMe2 as a viscous oil which was stored in the glove box. (CAUTION: all 
alkyl aluminum reagents used in this synthesis are pyrophoric and the LiAlH4 residue, if it still 
contains any Et2O, is also extremely pyrophoric) 
 
3.  Reactions of metallocene dichloride complexes with HAliBu2 and [Ph3C][B(C6F5)4]. 
Each zirconocene dichloride was weighed in a glove box into a 1-dram vial and 0.7 mL of 
benzene-d6 was added. Then 5 or 10 equiv of neat HAl
iBu2 were syringed in via microliter 
syringe. The vial was capped and shaken to dissolve the zirconocene dichloride and form the 
respective neutral hydride species. 1 equiv of [Ph3C][B(C6F5)4] was weighed into a second vial. 
The neutral zirconocene solution was added and the solution was mixed to generate the cationic 
hydride species. The solution was then transferred to a J-Young NMR tube for NMR analysis. 19F 
NMR spectra were identical for all species studied, showing three characteristic signals for the 
uncomplexed [B(C6F5)4]
− anion at -126.68 (br, 8F), -157.32 (t, 4F 21 Hz) and -161.19 ppm (br, 
8F). Therefore, only 1H NMR spectra are reported. In each case only a single product was 
observed by NMR. 
[rac-(SBI)Zr(µ-H)3(Al
iBu2)2][B(C6F5)4]. 2.0 mg (0.0045 mmol) rac-Me2Si(1-indenyl)2 ZrCl2, 
4.0 µL (0.022 mmol, 5 equiv) HAliBu2 and 4.1 mg (0.0044 mmol, 1 equiv) of [Ph3C][B(C6F5)4]. 
1H NMR (500 MHz, benzene-d6) δ 7.34 (d, 
3
JHH = 9 Hz, 4H, Ar-H), 6.71 (m, 2H, Ar-H), 6.63 (m, 
2H, Ar-H), 6.41 (d, 3JHH = 3 Hz, 2H, C5-H), 5.57 (d, 
3
JHH = 3 Hz, 2H, C5-H), 1.77 (n, 
3
JHH = 7 
Hz, 4H, iBu-CH), 0.94 (t, 3JHH = 7 Hz, 24H, 
iBu-CH3), 0.65 (s, 4H, Si(CH3)2), 0.34 (m, 1H, Zr-
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H2), 0.26 (dd,
 3
JHH = 14, 7 Hz, 4H, 
iBu-CH2), 0.15 (dd,
 3
JHH = 14, 7 Hz, 4H, 
iBu-CH2), -2.25 (d, 
2
JHH = 8 Hz, 2H, Zr-H2). 
 [rac-(EBI)Zr(µ-H)3(Al
iBu2)2][B(C6F5)4]. 1.3 mg (0.0031 mmol) rac-C2H4(1-indenyl)2ZrCl2, 3.0 
µL (0.016 mmol, 5 equiv) HAliBu2 and 3.0 mg (0.0033 mmol, 1 equiv) of [Ph3C][B(C6F5)4]. 
1H 
NMR (300 MHz, benzene-d6) δ 7.45 (m, 2H, Ar-H), 6.81 (m, 4H, Ar-H), 6.55 (s, 2H, Ar-H), 5.73 
(d, 3JHH = 3 Hz, 2H, C5-H), 5.55 (d, 
3
JHH = 3 Hz, 2H, C5-H), 3.32 (m, 4H, C2H4), 3.04 (m, 3H, 
C2H4), 1.75 (m, 
3
JHH = 7 Hz, 
iBu-CH), 0.93 (m, iBu-CH3), 0.19 (dd, 
3
JHH = 7, 3 Hz, 13H, 
iBu-
CH2), -0.29 (t, 
2
JHH = 8 Hz, 1H, Zr-H), -1.73 (d, 
2
JHH = 8 Hz, 2H, Zr-H2). 
[rac-(EBTHI)Zr(µ-H)3(Al
iBu2)2][B(C6F5)4]. 1.4 mg (0.0033 mmol) rac-C2H4(4,5,6,7-
tetrahydro-1-indenyl)2ZrCl2, 3.0 µL (0.016 mmol, 5 equiv) HAl
iBu2 and 3.1 mg (0.0034 mmol, 1 
equiv) of [Ph3C][B(C6F5)4]. 
1H NMR (300 MHz, benzene-d6) δ 5.80 (d, 
3
JHH = 3 Hz, 2H, Ar-H), 
5.26 (d, 3JHH = 3 Hz, 2H, Ar-H), 3.97 (m, 1H), 3.33 (m, 1H), 2.70 (m, 2H), 2.47 (m, 4H), 2.18 
(m, 6H), 1.88 (n, 7 Hz, iBu-CH), 1.55 (m, 2H), 1.30 (m, 7H), 0.97 (dt, 3JHH = 9, 5 Hz, 
iBu-CH3), 
0.35 (m, iBu-CH2), -0.47 (d, 
2
JHH = 6 Hz, 2H, Zr-H2), -1.09 (t, 
2
JHH = 6 Hz, 1H, Zr-H). 
[rac-Me2C(1-indenyl)2Zr(µ-H)3(Al
iBu2)2][B(C6F5)4]. 1.7 mg (0.0039 mmol) rac-Me2C(1-
indenyl)2ZrCl2, 3.5 µL (0.020 mmol, 5 equiv) HAl
iBu2 and 3.5 mg (0.0038 mmol, 1 equiv) of 
[Ph3C][B(C6F5)4]. 
1H NMR (300 MHz, benzene-d6) δ 7.29 (d, 
3
JHH = 9 Hz, 2H, Ar-H), 6.62 (m, 
4H, Ar-H), 6.35 (d, 3JHH = 3 Hz, 2H, C5-H), 5.33 (d, 
3
JHH = 3 Hz, 2H, C5-H), 1.76 (m, 4H, 
iBu-
CH), 1.69 (s, 3H, C(CH3)2), 0.91 (dd, 
3
JHH = 6, 4 Hz, 24H, 
iBu-CH3), 0.80 (m, Zr-H), 0.25 (qd, 
3
JHH = 15, 7, 7 Hz, 8H, 
iBu-CH2), -1.72 (d, 
2
JHH = 7 Hz, 2H, Zr-H2). 
[Me4C2(C5H4)2Zr(µ-H)3(Al
iBu2)2][B(C6F5)4]. 1.2 mg (0.0032 mmol) Me4C2(C5H4)2ZrCl2, 3.0 
µL (0.016 mmol, 5 equiv) HAliBu2 and 3.0 mg (0.0033 mmol, 1 equiv) of [Ph3C][B(C6F5)4]. 
1H 
NMR (300 MHz, benzene-d6) δ 5.95 (pt, 
3
JHH = 2 Hz, 4H, C5-H), 5.73 (t, 
3
JHH = 2 Hz, 4H, C5-H), 
1.86 (m, 3JHH = 7 Hz, 4H, 
iBu-CH), 0.94 (t, 3JHH = 9 Hz, 24H, 
iBu-CH3), 0.88 (s, 16H, C2(CH3)4), 
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0.36 (d, 3JHH = 7 Hz, 12H, 
iBu-CH2), -1.37 (d, 
2
JHH = 7.3 Hz, 2H, Zr-H2), -1.60 (t, 
2
JHH = 7.5 Hz, 
1H, Zr-H). 
[Me2Si(C5H4)2Zr(µ-H)3(Al
iBu2)2][B(C6F5)4]. 12.6 mg (0.0362 mmol) Me2Si(C5H4)2ZrCl2, 32.2 
µL (0.181 mmol, 5 equiv) HAliBu2 and 33.4 mg (0.0362 mmol, 1 equiv) of [Ph3C][B(C6F5)4]. 
1H 
NMR (300 MHz, benzene-d6) δ 6.22 (s, 4H, C5-H), 5.24 (s, 4H, C5-H), 1.83 (m, 
iBu-CH), 0.94 
(m, iBu-CH3), 0.35 (d, 
3
JHH = 7 Hz, 
iBu-CH2), 0.17 (s, 6H, Si(CH3)2), -1.22 (t, 
2
JHH = 8 Hz, 1H, 
Zr-H), -2.02 (d, 2JHH = 8 Hz, 2H, Zr-H2). 
[(Me2Si)2(C5H3)2Zr(µ-H)3(Al
iBu2)2][B(C6F5)4]. 1.0 mg (0.0025 mmol) (Me2Si)2(C5H3)2 ZrCl2, 
4.4 µL (0.025 mmol, 10 equiv) HAliBu2 and 2.3 mg (0.0025 mmol, 1 equiv) of [Ph3C][B(C6F5)4]. 
1H NMR (300 MHz, benzene-d6) δ 6.49 (d, 
3
JHH = 3 Hz, 4H, C5-H), 5.94 (t, 
3
JHH = 3 Hz, 2H, C5-
H), 1.82 (m, iBu-CH), 0.92 (m, iBu-CH3), 0.34 (d, 
3
JHH = 7 Hz, 
iBu-CH2), -0.08 (s, 6H, Si(CH3)2), 
-1.04 (t, 2JHH = 7 Hz, 1H, Zr-H), -2.03 (d, 
2
JHH = 7 Hz, 2H, Zr-H2). 
[(C5H5)2Zr(µ-H)3(Al
iBu2)2][B(C6F5)4]. 2.3 mg (0.0079 mmol) (C5H5)2ZrCl2, 7.0 µL (0.039 
mmol, 5 equiv) HAliBu2 and 7.3 mg (0.0079 mmol, 1 equiv) of [Ph3C][B(C6F5)4]. 
1H NMR (300 
MHz, benzene-d6) δ 5.59 (s, 10H, C5-H), 1.81 (n, 
3
JHH = 7 Hz, 4H, 
iBu-CH), 0.92 (d, 3JHH = 7 Hz, 
24H, iBu-CH3), 0.28 (d, 
3
JHH = 7 Hz, 8H, 
iBu-CH2), -2.27 (d, 
2
JHH = 8 Hz, 2H, Zr-H2), -2.39 (t, 
2
JHH = 8 Hz, 1H, Zr-H2). 
[(nBuC5H4)2Zr(µ-H)3(Al
iBu2)2][B(C6F5)4]. 2.9 mg (0.0072 mmol) (
nBuC5H4)2ZrCl2, 6.4 µL 
(0.036 mmol, 5 equiv) HAliBu2 and 6.5 mg (0.0070 mmol, 1 equiv) of [Ph3C][B(C6F5)4]. 
1H 
NMR (300 MHz, benzene-d6) δ 5.73 (m, 4H, C5-H), 5.67 (m, 4H, C5-H), 2.16 (t, 
3
JHH = 7 Hz, 5H, 
C5-
nBu), 1.86 (m, 3JHH = 7 Hz, 
iBu-CH), 1.20 (m, 16H, C5-
nBu), 0.96 (d, 3JHH = 7 Hz, 
iBu-CH3), 
0.88 (t, 3JHH = 7 Hz, 15H, C5-
nBu), 0.40 (d, 3JHH = 7 Hz, 
iBu-CH2), -1.61 (d, 
2
JHH = 8 Hz, 2H, Zr-
H2), -1.96 (t, 
2
JHH = 8 Hz, 1H, Zr-H). 
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[(Me3SiC5H4)2Zr(µ-H)3(Al
iBu2)2][B(C6F5)4]. 1.6 mg (0.0037 mmol) (TMSC5H4)2ZrCl2, 3.3 µL 
(0.019 mmol, 5 equiv) HAliBu2 and 3.5 mg (0.0038 mmol, 1 equiv) of [Ph3C][B(C6F5)4]. 
1H 
NMR (300 MHz, benzene-d6) δ 6.11 (s, 4H, C5-H), 6.01 (s, 4H, C5-H), 1.87 (m, 4H, 
iBu-CH), 
0.95 (d, J = 6 Hz, iBu-CH3), 0.46 (m, 
iBu-CH2), 0.03 (s, 18H, C5-SiMe3), -1.84 (d, 
2
JHH = 9 Hz, 
2H, Zr-H2), -2.30 (br, 1H, Zr-H). 
[(1,2-Me2C5H3)2Zr(µ-H)3(Al
iBu2)2][B(C6F5)4]. 1.0 mg (0.0029 mmol) (1,2-Me2C5H4)2 ZrCl2, 
5.1 µL (0.029 mmol, 10 equiv) HAliBu2 and 2.6 mg (0.0028 mmol, 1 equiv) of [Ph3C][B(C6F5)4]. 
1H NMR (300 MHz, benzene-d6) δ 5.86 (m, 2H, C5-H), 5.29 (d, 
3
JHH = 3 Hz, 4H, C5-H), 1.88 (m, 
3
JHH = 7 Hz, 
iBu-CH), 1.74 (s, 12H, C5-CH3), 0.97 (d, 
3
JHH = 6 Hz, 
iBu-CH3), 0.43 (d, 
3
JHH = 7 
Hz, iBu-CH2), -1.42 (d, 
2
JHH = 7 Hz, 2H, Zr-H2), -1.79 (br, 1H, Zr-H). 
[(C5H5)2Hf(µ-H)3(Al
iBu2)2][B(C6F5)4]. 4.3 mg (0.0113 mmol) (C5H5)2HfCl2, 20.2 µL (0.113 
mmol, 10 equiv) HAliBu2 and 10.4 mg (0.0113 mmol, 1 equiv) of [Ph3C][B(C6F5)4]. 
1H NMR 
(300 MHz, benzene-d6) δ 5.48 (s, 10H, C5-H), 1.80 (m, 
3
JHH = 7 Hz, 4H, 
iBu-CH), 0.92 (d, 3JHH = 
7 Hz, iBu-CH3), 0.26 (d, 
3
JHH = 7 Hz, 12H, 
iBu-CH2), -1.40 (d, 
2
JHH = 6 Hz, 2H, Zr-H2), -2.27 (t, 
2
JHH = 6 Hz, 1H, Zr-H). 
Attempted synthesis of [(C5H5)2Ti(µ-H)3(Al
iBu2)2][B(C6F5)4]. 4.5 mg (0.0181 mmol) 
(C5H5)2TiCl2 and 32 µL (0.18 mmol, 10 equiv) were combined in benzene-d6 in a J Young tube; 
this resulted in bubbling and a lavendar solution. 1H NMR (300 MHz, benzene-d6) δ 4.49 (s, H2). 
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Figure S-1: 1H NMR of 4.4 mM solution of [(EBI)Zr(µ-H)3(Al
iBu2)2][B(C6F5)4] in benzene-d6 
prepared with 5 equiv of HAliBu2. 
 
 
Figure S-2: 1H NMR of 4.7 mM solution of [(EBTHI)Zr(µ-H)3(Al
iBu2)2][B(C6F5)4] in benzene-
d6 prepared with 5 equiv of HAl
iBu2. 
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Figure S-3: 1H NMR of 5.6 mM solution of [Me2C(1-indenyl)2Zr(µ-H)3(Al
iBu2)2][B(C6F5)4] in 
benzene-d6 prepared with 5 equiv of HAl
iBu2. 
 
 
Figure S-4: gCOSY of sample in Figure S-3 showing location of central hydride resonance. 
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Figure S-5: 1H NMR of 4.6 mM solution of [Me4C2(C5H4)2Zr(µ-H)3(Al
iBu2)2][B(C6F5)4] in 
benzene-d6 prepared with 5 equiv of HAl
iBu2. 
 
 
Figure S-6: 1H NMR of 8.1 mM solution of [Me2Si(C5H4)2Zr(µ-H)3(Al
iBu2)2][B(C6F5)4] in 
benzene-d6 prepared with 5 equiv of HAl
iBu2. 
 10 
 
 
Figure S-7: 1H NMR of 3.6 mM solution of [(Me2Si)2(C5H3)Zr(µ-H)3(Al
iBu2)2][B(C6F5)4] in 
benzene-d6 prepared with 10 equiv of HAl
iBu2. 
 
 
Figure S-8: 1H NMR of 11 mM solution of [(C5H5)2Zr(µ-H)3(Al
iBu2)2][B(C6F5)4] in benzene-d6 
prepared with 5 equiv of HAliBu2. 
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Figure S-9: 1H NMR of 10 mM solution of [(C5H4
nBu)2Zr(µ-H)3(Al
iBu2)2][B(C6F5)4]
 
 
 in benzene-d6 prepared with 5 equiv of HAl
iBu2. 
 
 
Figure S-10: 1H NMR of 5.3 mM solution of [(C5H4TMS)2Zr(µ-H)3(Al
iBu2)2][B(C6F5)4] in 
benzene-d6 prepared with 5 equiv of HAl
iBu2. 
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Figure S-11: 1H NMR of 4.1 mM solution of [(1,2-Me2C5H3)2Zr(µ-H)3(Al
iBu2)2][B(C6F5)4] in 
benzene-d6 prepared with 10 equiv of HAl
iBu2. 
 
Figure S-12: 1H NMR of 16 mM solution of [(C5H5)2Hf(µ-H)3(Al
iBu2)2][B(C6F5)4] in benzene-d6 
prepared with 5 equiv of HAliBu2. 
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4.  Evidence for Formation of ClAliBu2 during synthesis of [(SBI)Zr(µ-H)3(Al
iBu2)2] 
[B(C6F5)4] 
Variable temperature spectra of a 3.1 mM solution of [(SBI)Zr(µ-H)3(Al
iBu2)2][B(C6F5)4] in 
toluene-d8 prepared as above show isobutyl-methyl resonances of ClAl
iBu2 at 1.01 ppm (
3
JHH = 7 
Hz) at –25 ºC (Figure S-13). At other temperatures the peaks are not sufficiently resolved to 
definitively identify the signals of ClAliBu2, however the overall shape of the peaks in the 
zirconocene spectra are consistent with this assignment. 
 
Figure S-13: Variable temperature 1H NMR spectra of the iBu-CH3 signals of toluene-d8 
solutions of [(SBI)Zr(µ-H)3(Al
iBu2)2][B(C6F5)4] (3.1 mM), a 1:1 mix of HAl
iBu2 and ClAl
iBu2 
(21 mM each) and pure ClAliBu2 (42 mM). 
 
5.  EXSY of [(SBI)Zr(µ-H)3(Al
iBu2)2][B(C6F5)4] 
A 3.1 mM solution of [(SBI)Zr(µ-H)3(Al
iBu2)2][B(C6F5)4] was prepared as above and an EXSY 
spectrum with a mixing time of 300 ms was collected (Figure S-14). Crosspeaks between the Al-
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H resonances for the three mixed HAliBu2 / ClAl
iBu2 clusters were visible as well as crosspeaks 
for free and bound isobutyl aluminum groups. No crosspeak was observed between free and 
complex-bound Al-H resonances. 
 
Figure S-14: EXSY spectrum of a 3.1 mM solution of [(SBI)Zr(µ-H)3(Al
iBu2)2][B(C6F5)4] 
collected with a mixing time of 300 ms at 25 ºC. Inset shows expansion of isobutyl CH3 
resonances with crosspeak for free and bound species marked. 
 
6.  Synthesis of [(SBI)Zr(µ-H)3(Al
iBu2)2][B(C6F5)4] 
In a glovebox 100.3 mg (0.2236 mmol) (SBI)ZrCl2 and 205.8 mg (0.2231 mmol, 1 equiv) of 
[Ph3C][B(C6F5)4] were weighed into a 25 mL round bottom flask. Approximately 15 mL of 
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toluene which had been vacuum transferred from titanocene was added resulting in an orange-red 
solution. 1.2 mL (6.7 mmol, 30 equiv) of HAliBu2 was syringed into the solution resulting in a 
green solution which faded to yellow upon stirring. A swivel frit with another 25 mL round- 
bottom flask was attached and the reaction vessel was taken to a high vacuum line. The reaction 
mixture was allowed to stir at room temperature for 30 minutes, following which toluene was 
removed in vacuo until no more liquid would come off, leaving 2-3 mL of a red solution. 
Approximately 10 mL of pentane was vacuum transferred from titanocene onto the reaction 
mixture. After stirring for one hour at room temperature a yellow precipitate was collected by 
filtration and washed twice with pentane. 128.0 mg (47% yield) of [(SBI)Zr(µ-
H)3(Al
iBu2)2][B(C6F5)4] was collected. 
1H NMR of the solid was indistinguishable with that 
formed in situ with the exception of the absence of peaks due to free HAliBu2 or ClAl
iBu2. 
Attempts to obtain elemental analysis of the compound were unsuccessful as the pale yellow 
solid was found to darken overnight at room temperature in a vacuum sealed ampoule. The solid 
could be stored for over one month at –40 ºC in a glovebox freezer suggesting that the low yield 
obtained in this reaction was due at least in part to the prolonged stirring at room temperature. 
 
7.  Reactions of zirconocene dichloride complexes with HAlMe2 and [Ph3C][B(C6F5)4]. 
Each zirconocene dichloride was weighed in a glove box into a 1-dram vial and a small quantity 
of HAlMe2 was added to the vial. Then 0.7 mL of benzene-d6 was added and the vial was capped 
and shaken to mix the reagents. The resulting solution was added to 1 equiv [Ph3C][B(C6F5)4] in 
a second vial. The final solution of the title complex was transferred to a J-Young tube for NMR 
analysis. 
[rac-(SBI)Zr(µ-H)3(AlMe2)2][B(C6F5)4]. 1.0 mg (0.0022 mmol) rac-Me2Si(1-indenyl)2 ZrCl2, 
1.4 mg (0.024 mmol, 11 equiv) HAlMe2 and 2.1 mg (0.0023 mmol, 1 equiv) of [Ph3C][B(C6F5)4]. 
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1H NMR (300 MHz, benzene-d6) δ 6.70 (dd, 
3
JHH = 20, 8 Hz, 6H, Ar-H), 6.29 (d, 
3
JHH = 2 Hz, 
2H, C5-H), 5.40 (d, 
3
JHH = 3 Hz, 2H, C5-H), 0.62 (s, 6H, Si(CH3)2), -0.15 (m, Zr-H), -2.06 (d, 
2
JHH = 4 Hz, 2H, Zr-H2). 
[rac-(EBI)Zr(µ-H)3(AlMe2)2][B(C6F5)4]. 1.8 mg (0.0043 mmol) rac-C2H4(1-indenyl)2 ZrCl2, 2.1 
mg (0.036 mmol, 8 equiv) HAlMe2 and 4.0 mg (0.0043 mmol, 1 equiv) of [Ph3C][B(C6F5)4]. 
1H 
NMR (300 MHz, benzene-d6) δ 7.42 (d, 
3
JHH = 9 Hz, 3H, Ar-H), 6.88 (dd, 
3
JHH = 21, 9 Hz, 7H, 
Ar-H), 6.64 (m, 2H, Ar-H), 5.60 (d, 3JHH = 3 Hz, 2H, C5-H), 5.49 (d, 
3
JHH = 3 Hz, 2H, C5-H), 
1.36 (s, 4H, C2H4), -1.00 (br, 1H, Zr-H), -1.45 (d,
 3
JHH = 9 Hz, 2H, Zr-H2). 
[rac-(EBTHI)Zr(µ-H)3(AlMe2)2][B(C6F5)4]. 2.0 mg (0.0046 mmol) rac-C2H4(4,5,6,7-
tetrahydro-1-indenyl)2ZrCl2, 2.2 mg (0.038 mmol, 8 equiv) HAlMe2 and 4.2 mg (0.0046 mmol, 1 
equiv) of [Ph3C][B(C6F5)4]. 
1H NMR (300 MHz, benzene-d6) δ 5.70 (d, 
3
JHH = 3 Hz, 2H, C5-H), 
5.15 (d, 3JHH = 3 Hz, 2H, C5-H), 2.50 (m, 3H), 2.17 (m, 6H), 1.41 (m, 6H), -0.94 (s, 2H, Zr-H2). 
[Me2Si(C5H4)2Zr(µ-H)3(AlMe2)2][B(C6F5)4]. 1.8 mg (0.0052 mmol) rac-Me2Si(C5H4)2 ZrCl2, 
2.4 mg (0.041 mmol, 8 equiv) HAlMe2 and 4.8 mg (0.0052 mmol, 1 equiv) of [Ph3C][B(C6F5)4]. 
1H NMR (300 MHz, benzene-d6) δ 5.91 (pt, 
3
JHH = 2 Hz, 4H, C5-H), 5.13 (pt, 
3
JHH = 2 Hz, 4H, 
C5-H), 0.21 (s, 6H, Si(CH3)2), -1.61 (t, 
2
JHH = 9 Hz, 1H, Zr-H), -2.93 (d, 
2
JHH = 7 Hz, 2H, Zr-H2). 
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Figure S-15: 1H NMR of 3.2 mM solution of [(SBI)Zr(µ-H)3(AlMe2)2][B(C6F5)4] in benzene-d6 
prepared with 6 equiv of HAlMe2. 
 
 
Figure S-16: gCOSY of sample from Figure S-15. 
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Figure S-17: 1H NMR of 6.1 mM solution of [(EBI)Zr(µ-H)3(AlMe2)2][B(C6F5)4] in benzene-d6 
prepared with 8.4 equiv of HAlMe2. 
 
 
Figure S-18: 1H NMR of 6.6 mM solution of [(EBTHI)Zr(µ-H)3(AlMe2)2][B(C6F5)4] in benzene-
d6 prepared with 8.1 equiv of HAlMe2. 
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Figure S-19: 1H NMR of 4.1 mM solution of [Me2Si(C5H4)Zr(µ-H)3(AlMe2)2][B(C6F5)4] in 
benzene-d6 prepared with 7.9 equiv of HAlMe2. 
 
8.  1H NMR of [(SBI)Zr(µ-H)3(AlMex
iBu2-x)2][B(C6F5)4]
 
The title complexes were prepared from a 3 mM solution of [(SBI)Zr(µ-H)3)(Al
iBu2)2]
+ prepared 
as above with 5 equiv of HAliBu2 and then adding 
1/3, 1, 2 or 3 equiv of AlMe3 to the NMR tube 
via microliter syringe. Shaking the sealed tube and collecting 1H NMR spectra yielded the spectra 
shown in Figure 6 of the text. 
 
To test the reversibility of this reaction, 1.2 mg (SBI)ZrMe2 (0.0029 mmol) was dissolved in 0.7 
mL benzene-d6 and added to 2.5 mg [Ph3C][B(C6F5)4] to give an orange cloudy solution of 
[(SBI)ZrMe]+. 2.6 µL HAliBu2 (0.015 mmol, 5 equiv) was then syringed in. Immediate 
1H NMR 
showed the presence of [(SBI)Zr(µ-H)3)(Al
iBu2)2]
+ which after stirring for 2 hours became the 
dominant species (Figure S-20). 
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Figure S-20: 1H NMR of 4.1 mM solution of [(SBI)Zr(µ-H)3(AlMex
iBu2-x)2][B(C6F5)4] in 
benzene-d6 prepared from [(SBI)ZrMe]
+ with 5.0 equiv of HAliBu2. 
 
9.  gCOSY of [(SBI)Zr(µ-H)3(AlMex
iBu2-x)2][Me-MAO]
− 
A 1.9 mM solution of [(SBI)Zr(µ-H)3(AlMex
iBu2-x)2][Me-MAO]
− was prepared by first adding 
50.6 mg MAO, which had been dried under vacuum at 50 ºC for 3 hours, to a 20 mL vial in the 
glove box. 3.5 mL of benzene-d6 was then added and the mixture was stirred to dissolve as much 
MAO as possible. The mixture was allowed to sit undisturbed for 30 minutes after which time 3 
mL of MAO solution was pipetted off leaving behind a gel. 2.6 mg of (SBI)ZrCl2 (0.0058 mmol) 
was then added to the solution to give an orange solution containing [(SBI)ZrMe2AlMe2]
+ and 
[(SBI)ZrMe+…MeMAO-]. 0.7 mL of this solution was transferred to a J Young tube and 15 µL 
HAliBu2 was added neat via microliter syringe. A gCOSY spectrum (Figure S-21) was obtained 
which showed coupling of the Zr(µ-H)2 peak to a downfield peak at 0.58 ppm consistent with the 
central Zr(µ-H). 
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Figure S-21: gCOSY of a solution of [(SBI)Zr(µ-H)3(AlMex
iBu2-x)2][MeMAO]
− showing 
coupling between hydride signals. 
 
10. 1H NMR spectrum of the dichloro-bridged cation [(SBI)Zr(µ-Cl)2Al
iBu2]
+ 
(Method 1A: HAliBu2 / ClAl
iBu2) 1.0 mg (SBI)ZrCl2 (2.2 µmol) and 2.1 mg [Ph3C][B(C6F5)4] 
(2.3 µmol, 1 equiv) were added to a 1-dram vial in the glove box. 0.7 mL benzene-d6 was added. 
0.4 µL HAliBu2 (2 µmol, 1 equiv) and 0.4 µL ClAl
iBu2 (2 µmol, 1 equiv) were added neat via 
microliter syringe. The mixture was shaken to yield a blue solution with blue oil. The mixture 
was transferred to a J-Young NMR tube and spectra were obtained (Figure S-22).  
 
 (Method 1B: HAliBu2 / ClAl
iBu2) The same species can be formed by first making the hydride 
cation, [(SBI)Zr(µ-H)3(Al
iBu2)2][B(C6F5)4], and then adding an excess of ClAl
iBu2. 1.0 mg 
(SBI)ZrCl2 (2.2 µmol) and 4.0 µL HAl
iBu2 (22 µmol, 10 equiv) along with 0.7 mL benzene-d6 
were added to a 1-dram vial in the glove box. The resulting solution was added to a second vial 
containing 2.2 mg [Ph3C][B(C6F5)4] (2.4 µmol, 1 equiv) resulting in a solution of the hydride 
cation. 8.0 µL of neat ClAliBu2 (41 µmol, 19 equiv) was then added via microliter syringe. The 
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mixture was shaken to yield a blue solution. The mixture was transferred to a J-Young NMR tube 
and spectra were obtained (Figure S-22). 
 
(Method 2: Et3Si
+) In the glove box, a slurry of 2.1 mg (SBI)ZrCl2 (4.7 µmol) was formed in a 
solution containing 4.3 mg (4.7 µmol, 1 equiv) of [Ph3C][B(C6F5)4] in 0.7 mL benzene-d6. The 
slurry was added to a J-Young tube and 0.9 µL ClAliBu2 (5 µmol, 1 equiv) was added to the side 
of the tube without mixing. The sample was removed from the box, frozen and the head space 
was evacuated on the high-vacuum line. 0.04 mL Et3SiH (300 µmol, 64 equiv) was vacuum-
transferred in from a storage flask containing CaH2. Upon thawing and mixing a blue solution 
and blue oil formed. The sample was pumped down to remove excess Et3SiH and then 
redissolved in benzene-d6. Spectra similar to those from Method A were obtained (Figure S-24). 
 
Figure S-22: 1H NMR spectrum of [(SBI)Zr(µ-Cl)2(Al
iBu2)]
+ formed from reaction with 1 equiv 
HAliBu2 and 1 equiv ClAl
iBu2. 
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Figure S-23: 1H NMR spectrum of [(SBI)Zr(µ-Cl)2(Al
iBu2)]
+ formed as a minor component 
from reaction of [(SBI)Zr(µ-H)2(Al
iBu2)2]
+ (major component) with 18 equiv ClAliBu2. 
 
 
Figure S-24: 1H NMR spectrum of [(SBI)Zr(µ-Cl)2(Al
iBu2)]
+ formed from reaction with 1 equiv 
[Et3Si]
+ formed in situ and 1 equiv ClAliBu2. 
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11. 1H NMR spectrum of the dichloro-bridged cation [(SBI)Zr(µ-Cl)2AlMe2]
+ 
1.0 mg (SBI)ZrMe2 (2.5 µmol) and 1.0 mg AlCl3 (7.5 µmol, 3 equiv) were weighed into a 1-dram 
vial. 1.4 µL (15 µmol, 6 equiv) AlMe3 was syringed onto the side of the vial. 2.3 mg (2.5 µmol, 1 
equiv) [Ph3C][B(C6F5)4] was weighed into a second 1-dram vial and was dissolved in 0.7 mL 
benzene-d6. The [Ph3C]
+ solution was added to the vial containing the zirconocene and mixed 
thoroughly to give a green solution which turned blue over the course of a few minutes. The 
solution was transferred to a J-Young tube for NMR analysis (Figure S-25). 
 
Figure S-25: 1H NMR spectrum of a 3.6 mM solution of [(SBI)Zr(µ-Cl)2(AlMe2)]
+. 
 
12. UV-vis spectra of [(SBI)Zr(µ-Cl)2(Al
iBu2)]
+ 
A 2.79 mM stock solution of (SBI)ZrCl(µ-H)2(Al
iBu2) was prepared by dissolving 12.5 mg 
(SBI)ZrCl2 (27.9 µmol) in 10.0 mL toluene, vacuum-transferred from titanocene, to which was 
added 14.9 µL HAliBu2 (83.6 µmol, 3.00 equiv). A 2.79 mM stock solution of [Ph3C][B(C6F5)4] 
was likewise prepared by dissolving 25.7 mg of [Ph3C][B(C6F5)4] in 10.0 mL toluene. For each 
UV-vis experiment 2.00 mL of each solution was combined and diluted to a volume of 10.0 mL 
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to afford a 0.558 mM solution of [(SBI)Zr(µ-H)3(Al
iBu2)2][B(C6F5)4] to which was then added an 
additional amount of neat HAliBu2 to afford solutions containing 3, 4, 5 or 10 equiv of HAl
iBu2. 
Following measurement of the UV-vis spectrum of each sample (Figure 5 of the text) enough 
HAliBu2 was added to reach 10 equiv relative to Zr. All samples afforded the same final spectrum 
regardless of how many equiv of HAliBu2 were initially added. 
To show the reversible nature of this equilibrium, successive 2.2 µL aliquots of ClAliBu2 
(11 µmol, 2.0 equiv) were added to one of the final samples containing 10 equiv HAliBu2, 
collecting UV-vis spectra between each addition (Figure S-26). 
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Figure S-26: UV-vis spectra of a 2.79 mM solution of [(SBI)Zr(µ-H)3(Al
iBu2)2]
+ made with 10 
equiv HAliBu2 upon successive additions of 2 equiv ClAl
iBu2. 
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13. Synthesis of [{(SBI)Zr(µ-Cl)}2][B(C6F5)4]2
 
In a glove box, 103.6 mg (SBI)ZrCl2 (231.0 mmol) and 213 mg (230.9 mmol, 1 equiv) 
[Ph3C][B(C6F5)4] were weighed into a 25 mL round bottom. A swivel frit and a second 25 mL 
round bottom were attached and 10 mL of toluene was added. The solution was degassed and 
0.35 mL Et3SiH was vacuum-transferred in at –78 ºC from a storage flask containing CaH2. The 
solution was allowed to warm to room temperature giving a green solution and a green oil. After 
stirring for 30 minutes the solvent was removed in vacuo and 10 mL pentane was vacuum-
transferred in from a titanocene-containing storage flask. After stirring for 5 minutes the reaction 
was filtered to give a green powder which was rinsed 3 times with pentane. 243.0 mg (96% yield) 
green powder was collected from the frit. [{(SBI)Zr(µ-Cl)}2][B(C6F5)4]2 was found to be 
completely insoluble in benzene, toluene, bromobenzene or a 1:1 mixture of toluene and 1,2-
difluorobenzene. Attempts to dissolve it in dichloromethane resulted in decomposition even at –
70 ºC. Upon exposure to air the green solid was found to rapidly change to a bright red color. 
 
Addition of 3.6 µL (18 µmol, 10 equiv) of ClAliBu2 to a slurry of 4.0 mg (1.8 µmol) of 
[{(SBI)Zr(µ-Cl)}2][B(C6F5)4]2 in 0.7 mL benzene-d6 followed by sonication and stirring 
overnight resulted in the spectrum shown in Figure S-27, which is closely similar to that shown 
in Figure S-24. In the absence of ClAliBu2 sonication and stirring [{(SBI)Zr(µ-Cl)}2][B(C6F5)4]2 
overnight in benzene-d6 did not yield any C5-H 
1H NMR signals. 
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Figure S-27: 1H NMR spectrum of [(SBI)Zr(µ-Cl)2(Al
iBu2)]
+ formed from reaction of 
[{(SBI)Zr(µ-Cl)}2][B(C6F5) 4]2 with 10 equiv ClAl
iBu2. 
 
14. 1H NMR spectrum of the cation [(SBI)Zr(µ-H)3(AlR2)2]
+
 with R = n-octyl 
A measured amount of AlOct3 solution in hexanes (25% by weight) was added to a J-Young tube 
via microliter syringe in the glovebox. The tube was evacuated for a minimum of 30 minutes to 
remove the hexanes. To this was then added a 3 mM solution of [(SBI)Zr(µ-H)3(Al
iBu2)2] 
[B(C6F5)4] prepared as above. 
1H-NMR spectra were collected with various ratios of AlOct3 to 
HAliBu2 (Figure S-28). 
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Figure S-28: 1H NMR of [(SBI)Zr(µ-H)3(Al
iBu2)2]
+ + AlOct3 with different equiv of HAl
iBu2 to 
AlOct3 of 5:10 (A), 10:10 (B) and 10:100 (C). 
 
15. 1H NMR spectrum of [(SBI)Zr(µ-H)3(AlR2)2]
+
 with R = n-octyl, isobutyl, methyl 
A solution of [(SBI)Zr(µ-H)3(AlR2)2]
+ was prepared as above with 10 equiv AlOct3 and 10 equiv 
HAliBu2 (similar to Figure S-28A). To this solution was added 2.1 µL AlMe3 (22 µmol, 10 
equiv). A 1H NMR spectrum was obtained (Figure S-29). 
 29 
 
Figure S-29: 1H NMR of [(SBI)Zr(µ-H)3(Al
iBu2)2]
+ + AlOct3 + AlMe3 with 10 equiv of 
HAliBu2, AlOct3 and AlMe3. 
 
16. Determination of the Equilibrium Constant for the Reaction [(SBI)Zr(µ-H)3(AlMe2)2]
+ + 
(AlMe3)2  [(SBI)ZrMe2AlMe2]
+ + (HAlMe2)3.  
A solution containing 3.1 mM [(SBI)Zr(µ-H)3(Al
iBu2)2]
+ was prepared by reacting 1.0 mg (2.2 
µmol) of (SBI)ZrCl2 and 3.0 µL (17 µmol, 5 equiv) of (HAl
iBu2)2 with 2.1 mg (2.2 µmol, 7.7 
equiv) of [Ph3C][B(C6F5)4] in 0.7 mL of toluene-d8 in a J-Young NMR tube in the glove box. 
1H-
NMR spectra were collected, at room temperature, after stepwise additions of 4.3 µL (45 µmol, 
20 equiv) increments of neat AlMe3 via microliter syringe in the glove box. Integrals of the Si-
CH3 signals for both zirconocene species, as well as of the H-Al and CH3-Al signals at 3.72 and 
0.31-0.34 ppm, respectively were monitored (Table S-1). All signals were invariant with reaction 
time and equilibrium was thus assumed to be established. The equilibrium constant Keq was 
calculated, in accord with Scheme 8 of the main article, using the expression 
                                                      
Keq = 
[(SBI)Zr(µ-Me)2AlMe2]
+.[(HAlMe2)3]
[(SBI)Zr(µ-H)3(AlMe2)2]
+ . [(AlMe3)2]  
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For these calculations, values for 70–210 equiv of AlMe3 were used, since the Si-CH3 
signal of [(SBI)ZrMe2AlMe2]
+ was first clearly observed at 70 equiv of AlMe3 (Figure S-30), 
while at higher AlMe3 concentrations [(SBI)ZrMe2AlMe2]
+ precipitated in the form of a red oil. 
The integrals of the CH3-Al signals were corrected to represent the concentration of (AlMe3)2 by 
subtracting 2 times the integrals of the Si-CH3 signal of [(SBI)Zr(µ-H)3(AlMe2)2]
+ at 0.58 ppm 
and six times the integral of the H-Al signal of (HAlMe2)3 and division of the resulting value by 
18. From eight such measurements, an average value of Keq = 0.97(15)*10
-2 was determined. 
Table S-1: Determination of Keq from concentration data for a reaction system containing 
[(SBI)Zr(µ-H)3(AlMe2)2]
+ and 70 - 210 equiv of AlMe3. 
Integrals Normalized “Concentration” a 
Si(CH3)2 
equiv 
AlMe3 
ZrH3Al2Me4 ZrAlMe4 ZrTOT 
H-Al 
CH3-
Al 
(SBI)ZrH3
+ (SBI)ZrAlMe4
+ (HAlMe2)3 (AlMe3)2
b 
Keq 
70 83.4 14.2 97.5 136.6 15315 13.9 2.4 45.5 796.0 0.0097 
90 83.4 14.1 97.5 144.2 19166 13.9 2.4 48.0 1007.5 0.0081 
110 80.3 17.2 97.6 148.8 23129 13.4 2.9 49.6 1226.4 0.0087 
130 77.4 19.9 97.3 161.4 28183 12.9 3.3 53.8 1503.3 0.0092 
150 74.8 22.6 97.3 167.0 32613 12.5 3.8 55.7 1747.8 0.0096 
170 75.6 21.1 96.7 186.2 39694 12.6 3.5 62.1 2134.8 0.0081 
190 67.3 30.5 97.8 162.4 37651 11.2 5.1 54.1 2030.1 0.0121 
210 65.9 31.3 97.2 185.4 46103 11.0 5.2 61.8 2492.1 0.0118 
        
average Keq 
± 
0.0097 
±0.0015 
a “Concentration” refers to normalized integrals, such that tabulated concentrations are accurate 
relative to each other but are not absolute concentrations. Conversions to absolute concentrations 
were omitted, since any such factors would cancel out in determining the dimensionless value of 
Keq. The total absolute concentration of Zr in all solution was 3.1 mM. 
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Figure S-30: 1H-NMR spectra of a 3.1 mM solution of [(SBI)Zr(µ-H)3(Al
iBu2)2]
+ with 3.5 equiv 
of free HAliBu2 upon addition of 50-210 equiv of AlMe3 relative to Zr. 
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17. X-ray Crystallography Details 
Data for [(SBI)Zr(µ-H)3(Al
iBu2)2][B(C6F5)4]⋅½(C7H8) (1) and [(Me2Si)2(C5H3)Zr(µ-H)3(Al
iBu2)2] 
[B(C6F5)4] (2) were collected on a Bruker KAPPA APEX II using Mo Kα X-ray source (λ = 
0.71073 Å). The crystals were mounted on a glass fiber under Paratone-N oil and all data were 
collected at 100 K. Data were collected using ω scans. Data collection and cell parameter 
determination were conducted using the APEX2 program. Integration of the data frames and final 
cell parameter refinement were performed using SAINT software. Absorption correction of the 
data was carried out semi-empirically based on equiv reflections for 2 for 1 no absorption 
correction was applied. Subsequent calculations were carried out using SHELAXS software. 
Structure determination was done using direct methods and difference Fourier techniques. All 
hydrogen atom positions were idealized, and rode on the atom of attachment with exceptions 
noted in the subsequent paragraph. A summary of relevant crystallographic data is presented in 
Table S-2. 
 
For both complexes, the hydrides were located in the difference maps and their positions were 
refined. For 2 no restraints were applied while for 1 the thermal factors were restrained to be 1.2 
times the Ueq of the corresponding metal atoms. Additionally in 1 all six-membered rings were 
constrained to be regular hexagons. The toluene was constrained to be flat and the atomic 
displacement parameters (ADP’s) to simulate isotropic behavior. The eight isobutyl groups were 
restrained to have the same geometry with no target values for the bond lengths. The ADP’s of 
the iBu groups were restrained to simulate isotropic behavior however no restraints were placed 
on their sizes. 
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Table S-2: X-ray Crystallographic Data for all compounds 
 [(SBI)Zr(µ-H)3(Al
iBu2)2]
+ [(Me2Si)2(C5H3)Zr(µ-H)3(Al
iBu2)2]
+ 
Empirical Formula [C36H57Al2SiZr][C24BF20]
-
⋅½(C7H8)  [C30H54Al2Si2ZrH3]+ [C24BF20]‾ 
Crystal Habit, color Block, yellow Blade, colorless 
Crystal Size (mm) 0.27 x 0.22 x 0.09 0.28 x 0.20 x 0.04 
Crystal System Orthorhombic Monoclinic 
Space Group P212121 P21/n 
Volume (Å3) 12669.3(9) 5766.9(5) 
a (Å) 17.3916(7) 16.2579(8) 
b (Å) 26.6355(12) 17.1922(7) 
c (Å) 27.3497(12) 21.1975(10) 
α (°) 90 90 
β (°) 90 103.262(3) 
γ (°) 90 90 
Z 8 4 
Formula weight (g/mol) 1388.20 1298.17 
Density (calculated) (Mg/m3) 1.456 1.495 
Absorption coefficient (mm-1) 0.318 0.364 
F000 5656 2640 
Total no. reflections 115139 75246 
Unique reflections 23731 12697 
Final R indices [I > 2σ(I)] 
R1 = 0.0623, wR2 = 0.0749 
13557 reflections 
R1 = 0.0422, wR2 = 0.0681 
8862 reflections 
R indices (all data) R1 = 0.1201, wR2 = 0.0779 R1 = 0.0795, wR2 = 0.0719 
Largest diff. peak and hole (e-Å-3) 0.703 and -0.470 0.741 and -0.489 
GOF 1.804 1.883 
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18. Selected distances and angles for the cation [(SBI)Zr(µ-H)3(Al
iBu2)2]
+  
Bond distances (Å) nonbonding distances (Å) bond angles (°) 
Zr1-H1H 1.92(4) Zr1-Al1 3.1779(20) H1H-Zr1-H3H 123.1(14) 
Zr1-H2H 1.88(3) Zr1-Al2 3.0945(19) H1H-Zr1-H2H 56.7(13) 
Zr1-H3H 1.99(4)   H2H-Zr1-H3H 66.4(14) 
Al1-H1H 1.58(3)   H1H-Al2-H2H 60.4(16) 
Al1-H2H 1.95(4)   H2H-Al1-H3H 70.7(15) 
Al2-H2H 1.92(3)   ctr1-Zr1-ctr2 126.514(24) 
Al2-H3H 1.73(3)     
Zr1-ctr1 2.1897(5)     
Zr1-ctr2 2.1913(5)  (ctr1: C1A-C5A, ctr2: C10A-C14A) 
      
Zr2-H4H 1.99(4) Zr2-Al3 3.1015(20) H4H-Zr2-H6H 129.4(14) 
Zr2-H5H 1.92(3) Zr2-Al4 3.1917(18) H4H-Zr2-H5H 64.9(14) 
Zr2-H6H 1.94(4)   H5H-Zr2-H6H 65.0(14) 
Al3-H6H 1.75(3)   H5H-Al3-H6H 70.3(16) 
Al3-H5H 1.85(4)   H4H-Al4-H5H 66.0(15) 
Al4-H5H 2.07(4)   ctr3-Zr2-ctr4 126.868(24) 
Al4-H4H 1.78(3)     
Zr2-ctr3 2.1883(5)     
Zr2-ctr4 2.2055(5)  (ctr3: C1B-C5B, ctr4: C10B-C14B) 
 
19. Selected distances and angles for the cation [(Me2Si)2(C5H3)2Zr(µ-H)3(Al
iBu2)2]
+ 
Bond distances (Å) nonbonding distances (Å) bond angles (°) 
Zr1-H1H 1.9786(1) Al1-Zr1 3.0893(1) H1H-Zr1-H2H 64.795(2) 
Zr1-H2H 2.0850(1) Al2-Zr1 3.0831(1) H1H-Zr1-H3H 128.616(3) 
Zr1-H3H 1.9495(1)   H2H-Zr1-H3H 63.840(2) 
Al1-H1H 1.6449(1)   H1H-Al1-H2H 75.844(2) 
Al1-H2H 1.8871(1)   H1H-Al2-H3H 74.995(2) 
Al2-H2H 1.8290(1)   ctr1-Zr1-ctr2 122.646(2) 
Al2-H3H 1.6747(1)     
Zr1-ctr1 2.1568(1)     
Zr1-ctr2 2.1543(1)  (ct1: C1-C5, ctr2: C6-C10) 
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